Vir Biotechnology reports early progress in antibody treatment for Covid-19

Vir Biotechnology, a San Francisco-based biotechnology firm, said laboratory testing showed two of its antibody drugs appeared to neutralize the coronavirus that causes Covid-19.

Click to view original post